Jack A. Khattar

2020

In 2020, Jack A. Khattar earned a total compensation of $6.7M as Chief Executive Officer, President & Secretary at Supernus Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$815,500
Option Awards$3,955,883
Salary$836,400
Stock Awards$1,032,813
Other$28,451
Total$6,669,046

Khattar received $4M in option awards, accounting for 59% of the total pay in 2020.

Khattar also received $815.5K in non-equity incentive plan, $836.4K in salary, $1M in stock awards and $28.5K in other compensation.

Rankings

In 2020, Jack A. Khattar's compensation ranked 1,500th out of 13,090 executives tracked by ExecPay. In other words, Khattar earned more than 88.5% of executives.

ClassificationRankingPercentile
All
1,500
out of 13,090
89th
Division
Manufacturing
562
out of 5,618
90th
Major group
Chemicals And Allied Products
203
out of 2,251
91st
Industry group
Drugs
169
out of 1,951
91st
Industry
Pharmaceutical Preparations
117
out of 1,456
92nd

Pay ratio

Jack A. Khattar's Pay$6,669,046
Median Employee's Pay$148,804
Pay Ratio

45

to 1

In 2020, the annual total compensation of Jack A. Khattar was $6,669,046.

The annual total compensation of the median employee at Supernus Pharmaceuticals was $148,804.

The ratio of Jack A. Khattar's pay to the pay of median employee was therefore 45 to one.

Source: SEC filing on April 30, 2021.

Khattar's colleagues

We found five more compensation records of executives who worked with Jack A. Khattar at Supernus Pharmaceuticals in 2020.

2020

James Kelly

Supernus Pharmaceuticals

Chief Financial Officer

2020

Stefan Schwabe

Supernus Pharmaceuticals

Chief Medical Officer

2020

Gregory Patrick

Supernus Pharmaceuticals

Chief Financial Officer

2020

Padmanabh Bhatt

Supernus Pharmaceuticals

Chief Scientific Officer

2020

Tami RN

Supernus Pharmaceuticals

Senior Vice President, Regulatory Affairs

News

In-depth

You may also like